期刊文献+

脑膜炎奈瑟球菌免疫组合物的制备及其免疫效果的检测

Preparation and immune effect of meningococcal immunogenic conjugates
原文传递
导出
摘要 目的利用不同的载体对脑膜炎奈瑟球菌(Neisseria meningitidis,Nm)A群、B群、C群、W135群和Y群进行偶联,比较不同的免疫组合物的免疫效果。方法将Nm A群、W135群和Y群多糖与CRM197偶联;将B群Nm菌种进行传代、培养、提取并纯化外膜蛋白,将外膜蛋白与C群多糖偶联。采用冻干水化法将蛋白质-多糖偶联物与脂质体(以明矾作为对照)混合后,免疫豚鼠,对不同Nm免疫组合物的杀菌滴度进行检测。结果各免疫组合物针对相应的Nm血清群具有不同的免疫作用,与C群多糖和B群外膜蛋白直接混合后免疫相比,C群多糖与B群外膜蛋白以共价键偶联后形成的免疫复合物免疫豚鼠,可引发更高滴度的杀菌抗体;而与以明矾作为佐剂相比,以脂质体作为佐剂均具有更好的免疫促进作用,其中以A群和Y群的免疫增强效果明显(P<0.05)。结论以不同抗原共价键偶联的方式较抗原直接混合后制备的Nm免疫组合物具有更高的杀菌滴度,同时以脂质体作为佐剂有利于增强脑膜炎疫苗的免疫效果。 Objective To conjugate Neisseria meningitidis (Nm) groups A, B, W135 and Y by using various carriers, and compare the immune effects of conjugates. Methods The polysaccharides of Nm groups A, W135 and Y were conjugated to CRM197. The seeds of Nm group B were subcultured, from which outer membrane protein was extracted, purified and conjugated to polysaccharide group C. The protein-polysaccharide conjugates were mixed with liposome by freeze- dried hydratation and immunized to guinea pigs, using alum as control, and determined for bactericidal titer. Results The conjugates showed various immune effects against Nm of the corresponding serogroups. Compared with that of direct mixture, the covalent conjugate of polysaccharide group C and outer membrane protein group B induced high bactericidal titer in guinea pigs. The immunopotentiation of conjugates using liposome as adjuvant was superior to that using alum as control, while the immune effects of conjugates groups A and Y were enhanced significantly (P 〈 0. 05 ). Conclusion The immunogenic conjugates of Nm prepared with various antigens by covalent conjugation showed higher bactericidal titer than those by direct mixing. In addition, liposome as an adjuvant was beneficial to the enhancement of immune effect of Nm vaccine.
出处 《中国生物制品学杂志》 CAS CSCD 2014年第6期770-774,779,共6页 Chinese Journal of Biologicals
基金 深圳市科创委项目资助(2108K030BA GGJS20130331152344401)
关键词 脑膜炎奈瑟球菌 载体蛋白 偶联 脂质体 杀菌滴定度 Neisseria meningitidis (Nm) Carrier protein Conjugation Liposome Bactericidal titer
  • 相关文献

参考文献14

  • 1Caesar NM,Myers KA,Fan X.Neisseria meningitidis serogroup B vaccine development[J].Microb Pathog,2013,57(1):33-40.
  • 2Borrow R,Abad R,Trotter C,et al.Effectiveness of meningococcal serogroup C vaccine programmes[J].Vaccine,2013,31(41):4477-4486.
  • 3Seib KL,Oriente F,Adu-Bobie J,et al.Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection[J].Vaccine,2010,28(12):2416-2427.
  • 4Morley SL,Pollard AJ.Vaccine prevention of meningococcal disease,coming soon[J].Vaccine,2002,20(5-6):666-687.
  • 5φstergaard L,Van der Wielen M,Bianco V,et al.Persistence of antibodies for 42 months following vaccination of adolescents with a meningococcal serogroups A,C,W-135,and Y tetanus toxoid conjugate vaccine(MenACWY-TT)[J].Int J Infect Dis,2013,17(3):e173-e176.
  • 6Tontini M,Berti F,Romano MR,et al.Comparison of CRM197,diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines[J].Vaccine,2013,31(42):4827-4833.
  • 7启龙股份公司.包含脑膜炎奈瑟球菌血清群b和c抗原和其它抗原的组合物[P]:中国,CN 1507916 A,2004-06-30.
  • 8Dull PM,McIntosh ED.Meningococcal vaccine developmentfrom glycoconjugates against MenACWY to proteins against MenB-potential for broad protection against meningococcal disease[J].Vaccine,2012,30(Suppl 2):B18-B25.
  • 9Bolhassani A,Javanzad S,Saleh T,et al.Polymeric nanoparticles:Potent vectors for vaccine delivery targeting cancer and infectious diseases[J].Hum Vaccin Immunother,2014,10(2):321-332.
  • 10TontiniM,Berti F,Romano MR,et al.Comparison of CRM197,diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines[J].Vaccine,2013,31(42):4827-4833.

二级参考文献18

  • 1赵荣乐,郑光宇.流脑与脑膜炎奈瑟球菌[J].生物学通报,2005,40(6):6-8. 被引量:3
  • 2原灵,郭维植,谢一俊,董新平,林杰.从2例脑膜炎患者的脑脊液中首次检出C群脑膜炎球菌[J].中国预防医学杂志,2006,7(2):133-135. 被引量:11
  • 3朱展鹰,李东悦,黄国超,欧志洪.流脑的流行及免疫预防概况[J].中国热带医学,2005,5(4):853-854. 被引量:10
  • 4李艺星,李军宏,尹遵栋,宁夏,邵祝军,徐丽,高源,李马超,梁晓峰.中国2005/2006年度流行性脑脊髓膜炎流行病学特征分析[J].中国计划免疫,2007,13(3):193-196. 被引量:28
  • 5Chu CY,Schneerson R,Robbins JD,et al.Further studies on the immunogenicity of Heamophilus influenzae type B and Pneumoccal type 6A polysaccharide-protein conjugates.Infect Immun,1983,40:245-256.
  • 6Paton JC,Lock RA,Lee CJ,et al.Purification and immunogenicity of genetically obtained pneumoniae type 19F polysaccharide.Infection and immunity,1991,59(7):2297-2304.
  • 7Schneerson R,Barrera O,Sutton A,et al.Preparation,characterization and immunogenicity of Haemophilus influenzae type B polysaccharide-protein conjugates.J Exp Med,1980,152:361-376.
  • 8Ouchterlony O.Diffusion-in gel methods for immunological analysis.Prog Allergy,1962,6:30-154.
  • 9Shyamala GNS,Roberton DM,Hosking CS.Human-Iso-type-specific ELISA for antibody to polysaccharide.J Clin Microbiol,1988,26(8):1575-1579.
  • 10Frasch CE,Chapman S.Classification of Neisseria meningitidis group B into distinct serotypes I.Serological typing by a microbactericidal method.Infect Immun,1972,5:98-105.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部